glp 1 drugs and blood clots Wegovy Clots: Do GLP-1 Increase Your Risk of DVT and PE? GLP-1 Agonists in Cardiovascular Diseases:

According to the Joi + Blokes GLP-1 page, the most common side effects reported with semaglutide and tirzepatide include nausea, vomiting, diarrhea, constipation, bloating or gas, decreased appetite, and fatigue

Current GLP-1 patches contain herbal supplements rather than actual hormones, making them ineffective alternatives to FDA-approved injectable medications

By contrast, the higher E-values for the study outcomes, shown in Table 2 and Table 3, suggest that substantial unmeasured confounding would be required to fully explain the observed associations

Some GLP-1 users report low energy from eating less, while others find they have fewer crashes, perhaps because of better blood sugar regulation

You might hear them called GLP-1 analogs or incretin mimetics. While the first version was approved in 2005, modern options like Ozempic, Wegovy, and Zepbound have revolutionized the field by offering once-weekly dose to get superior results